Erythromycin treatment in diffuse panbronchiolitis

Current Opinion in Pulmonary Medicine

Volumn 4, Issue 2, 1998, Pages 116-121

  Kudoh, Shoji ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ERYTHROMYCIN;

BRONCHIOLITIS; BRONCHUS; DRUG EFFECT; FEMALE; HUMAN; LYMPHOCYTE; MACROPHAGE; MALE; MORTALITY; NEUTROPHIL; PATHOLOGY; PROGNOSIS; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BRONCHI; BRONCHIOLITIS; ERYTHROMYCIN; FEMALE; HUMANS; LYMPHOCYTES; MACROPHAGES; MALE; NEUTROPHILS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032015311     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199803000-00010     Document Type: Article

References (38)

1. Nakata K, Inatomi K: Case study on diffuse panbronchiolitis patients diagnosed via histopathological examination. Annual report of the Research Committee on Interstitial Pneumonia. Ministry of Health and Welfare, Japan; p. 25.
2. Kudoh S, Kimura H: Clinical effect of low-dose long-term administration of macrolides on diffuse panbronchiolitis. Nippon Kyobu Shikkan Gakkai Zasshi 1984, 254(suppl):254.
3. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH, Kimura H, Sugiyama Y: Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis [in Japanese]. Nippon Kyobu Shikkan Gakkai Zasshi 1987, 25:632-642.
4. Kudoh S, Yamaguchi T, Kurashima A: Long-term therapeutic effects of erythromycin on difuse panbronchiolitis: a retrospective study. Annual report of the Research Committee on Interstitial Lung Disease [in Japanese]. 1989, Ministry of Health and Welfare, Japan.
5. Yamamoto M, Kondo A, Tamura M, Izumi T, Ina Y, Noda M: Long-term therapeutic effects of erythromycin and new quinolone antibacterial agents on diffuse panbronchiolitis [in Japanese]. Nippon Kyobu Shikkan Gakkai Zasshi 1990, 28:1305-1313.
6. Yamamoto M, Kudoh S, Ina Y, Tamura A: Clinical efficacy of erythromycin for patients with diffuse panbronchiolitis: a double blind study [in Japanese]. 1991, Ministry of Health and Welfare, Japan.
7. Kudoh S, Azuma A, Izumi T, Yamamoto M, Ando M: Improvement of survival in patients with diffuse panbronchiolitis in Japan: contribution of low-dose erythromycin treatment. Am J Respir Crit Care Med, in press.
8. Nagai H, Shishido H, Yoneda R, Yamaguchi E, Tamura A, Kurashima A: Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991, 58:145-1459.
9. Goswami SK, Kivity S, Marom Z: Erythromycin inhibits respiratory glycoconjugate secretion from human airway in vitro. Am Rev Respir Dis 1990, 141:72-78.
10. Tamaoki J, Isono K, Sakai N, Kanemura T, Konno K: Erythromycin inhibits CI secretion across canine tracheal epithelial cells. Eur Respir J 1992, 5:234-238.
11. Mikami M: Clinical and pathophysiological significance of neutrophil elastase in sputum and the effect of erythromycin in chronic respiratory diseases. Nippon Kyobu Shikkan Gakkai Zasshi 1992, 29:72-83.
12. Ichikawa Y, Ninomiya H, Koga, Tanaka M, Kinoshita M, Tokunaga N, Yano T, Oizumi K: Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992, 146:196-203.
13. Umeki S: Anti-inflammatory action of erythromycin: its inhibitory effect on neutrophil NADPH oxidase activity. Chest 1993, 104:1191-1193.
14. Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, Kawakami K, Fukushima K, Hiratani K, Hara K: A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993, 147:153-159.
15. Ooishi K, Sonoda F, Kobayashi S, Matsumoto K: Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immun 1994, 62:4145-4152.
16. Takizawa H, Desaki M, Ohtoshi T, Kawasaki S, Kohyama T, Sato M, Tanaka M, Kasama T, Kobayashi K, Nakajima J, Ito K: Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem Biophys Res Commun 1995, 210:781-786.
17. Takizawa H, Desaki M, Ohtoshi T, Kawasaki S, Kohyama T, Sato M, Tanaka M, Kasama T, Kobayashi K, Nakajima J, Ito K: Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am J Respir Crit Care Med 1997, 156:266-271. The first paper to report on the inhibitory action of erythromycin to IL-8 expression of epithelial cells in vitro.
18. Khair OA, Devalia JL, Abdelaziz MM, Sapsford RJ, Davis RJ: Effect of erythromycin on Haemophilus influenzas endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur Respir J 1995, 8:1451-1457.
19. Keicho N, Kudoh S, Yotsumoto H, Akagawa KS: Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J Antibiot (Tokyo) 1993, 46:1406-1413.
20. Keicho N, Kudoh S, Yotsumoto H, Akagawa KS: Erythromycin promotes monocyte to macrophage differentiation. J Antibiot (Tokyo) 1994, 47:80-89.
21. Iino Y, Toriyama M, Kudo K, Natori Y, You A: Erythromycin inhibition of lipopolysaccharide-stimulated tumour necrosis factor-alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol 1992, 101:16-20.
22. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K: Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 1996, 63:42-48.
23. Umeki S: Anti-inflammatory action of erythromycin: its inhibitory effect on neutrophil NADPH oxidase activity. Chest 1993, 104:1191-1193.
24. Nelson S, Summer WR, Terry PB, Warr GA, Jakab GJ: Erythromycin induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis 1987, 136:1207-1212.
25. Hirata T, Matsunobe S, Matsui Y, Kado M, Mikiya K, Oshima S: Effect of erythromycin on the generation of neutrophil chemiluminescence in vitro. Nippon Kyobu Shikkan Gakkai Zasshi 1990, 28:1066-1071.
26. Oda H, Kadota JI, Kohno S, Hara K: Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis. Chest 1994, 106:1116-1123.
27. Hojo M, Fujita I, Hamasaki Y, Miyazaki M, Miyazaki S: Erythromycin does not directly affect neutrophil functions. Chest 1994, 105:520-523.
28. Suez D, Szefler SJ: Excessive accumulation of mucus in children with asthma: a potential role for erythromycin? [case discussion], J Allergy Clin Immunol 1986, 77:330-334.
29. Miyatake H, Taki F, Taniguchi H, Suzuki R, Takagi K, Satake T: Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991, 99:670-673.
30. Konno S, Asano K, Kurokawa M, Ikeda K, Okamoto K, Adachi K: Anti-asthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Immunol 1994, 105:308-316.
31. Yanagihara K, Tomono K, Sawai T, Hirakata Y, Kadota J, Koga H, Tashiro T, Kohno S: Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 1997:337-342.
32. Tamaoki J, Takeyama K, Tagaya E, Konno K: Effect of clarithromycin on sputum properties and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother 1995, 39:1688-1690.
33. Rubin BK, Druce H, Ramirez OE, Palmer R: Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. Am J Respir Crit Care Med 1997, 155:2018-2023.
34. Suzuki H, Shimomura A, Ikeda K, Oshima T, Takasaka T: Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of patients. Tohoku J Exp Med 1997, 182:115-124.
35. Cole PCA: "Vicious circle" hypothesis of the pathogenesis of bronchiectasis. Eur J Respir Dis 1986, 69(suppl):6-15.
36. Kondo Y, Torii K, Omura S, Itoh Z: Erythromycin and its derivatives with motilin-like biological activities inhibit the specific binding of 1251-motilin to duodenal muscle. Biochem Biophys Res Commun 1988, 150:877-882.
37. Peeters TL: Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993, 105:1886-1899.
38. Kino M: A study on patients with diffuse panbronchiolitis diagnosed by pathological examination. Annual report of the Research Committee on Interstitial Lung Disease [in Japanese]. 1989, Ministry of Health and Welfare, Japan.